Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 23% ± 6% | |
| goblet cell | 3 studies | 17% ± 2% |
Insufficient scRNA-seq data for expression of ARHGEF16 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 1201.82 | 328 / 328 | 98% | 39.14 | 175 / 178 |
| thymus | 100% | 2200.02 | 652 / 653 | 93% | 19.28 | 562 / 605 |
| prostate | 93% | 2110.60 | 228 / 245 | 99% | 23.56 | 496 / 502 |
| kidney | 100% | 3211.17 | 89 / 89 | 89% | 22.65 | 803 / 901 |
| lung | 88% | 660.99 | 510 / 578 | 96% | 24.23 | 1109 / 1155 |
| breast | 90% | 993.30 | 411 / 459 | 93% | 17.88 | 1040 / 1118 |
| stomach | 81% | 2238.91 | 289 / 359 | 97% | 32.14 | 276 / 286 |
| intestine | 66% | 2423.27 | 641 / 966 | 98% | 40.26 | 516 / 527 |
| esophagus | 55% | 1135.47 | 801 / 1445 | 97% | 28.09 | 178 / 183 |
| bladder | 57% | 804.86 | 12 / 21 | 93% | 27.39 | 467 / 504 |
| liver | 88% | 681.58 | 199 / 226 | 55% | 10.13 | 222 / 406 |
| ovary | 33% | 168.36 | 60 / 180 | 78% | 9.22 | 335 / 430 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 39.95 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 28.28 | 1 / 1 |
| uterus | 9% | 78.89 | 15 / 170 | 87% | 32.05 | 401 / 459 |
| skin | 72% | 740.52 | 1298 / 1809 | 24% | 2.63 | 112 / 472 |
| adipose | 55% | 309.20 | 667 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 21% | 1.61 | 17 / 80 |
| brain | 17% | 79.60 | 457 / 2642 | 2% | 0.14 | 12 / 705 |
| spleen | 15% | 57.98 | 35 / 241 | 0% | 0 | 0 / 0 |
| muscle | 8% | 46.59 | 68 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 2% | 9.21 | 6 / 258 | 3% | 0.71 | 7 / 230 |
| blood vessel | 4% | 17.23 | 53 / 1335 | 0% | 0 | 0 / 0 |
| heart | 3% | 9.00 | 22 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 1.79 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
| GO_0060326 | Biological process | cell chemotaxis |
| GO_0090630 | Biological process | activation of GTPase activity |
| GO_0005829 | Cellular component | cytosol |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0030165 | Molecular function | PDZ domain binding |
| GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0030971 | Molecular function | receptor tyrosine kinase binding |
| GO_0031267 | Molecular function | small GTPase binding |
| Gene name | ARHGEF16 |
| Protein name | Alternative protein ARHGEF16 Rho guanine nucleotide exchange factor 16 ARHGEF16 Rho guanine nucleotide exchange factor 16 (Ephexin-4) |
| Synonyms | EPHEXIN4 NBR |
| Description | FUNCTION: Guanyl-nucleotide exchange factor of the RHOG GTPase stimulating the exchange of RHOG-associated GDP for GTP. May play a role in chemotactic cell migration by mediating the activation of RAC1 by EPHA2. May also activate CDC42 and mediate activation of CDC42 by the viral protein HPV16 E6. . |
| Accessions | A0A2X0SFX5 Q5VV41 B0QZD4 ENST00000418137.1 ENST00000378371.6 [Q5VV41-2] ENST00000378378.9 [Q5VV41-1] ENST00000445297.5 B0QZD3 ENST00000378373.5 [Q5VV41-2] L8EAP0 |